According to Pallavi Mishra-Kalyani, deputy director of the Division of Biometrics at the Center for Drug Evaluation and Research (CDER) at the FDA, the FDA considers relevance and reliability when evaluating whether registry data are fit for purpose for regulatory decision-making.
Lisa Park is a leading technology journalist with 11 years of experience covering Silicon Valley, emerging technologies, and digital innovation. Lisa holds a Master’s in Computer Science and Her expertise spans artificial intelligence, blockchain technology, cybersecurity, and venture capital. She has exclusive access to tech executives, startup founders, and industry insiders, making her a trusted voice in technology reporting.
This news is powered by News Directory 3 
